Holen Sie sich die Stockscreener-App
366.65
1.00%
3.62
Handel nachbörslich:
366.65
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$363.03
Offen:
$364.8
24-Stunden-Volumen:
1.00M
Relative Volume:
0.76
Marktkapitalisierung:
$71.32B
Einnahmen:
$325.78B
Nettoeinkommen (Verlust:
$1.64B
KGV:
44.10
EPS:
8.3139
Netto-Cashflow:
$3.61B
1W Leistung:
+2.10%
1M Leistung:
+3.13%
6M Leistung:
+26.56%
1J Leistung:
+46.28%
1-Tages-Spanne:
$363.78
$368.36
1-Wochen-Bereich:
$356.24
$368.36
52-Wochen-Spanne:
$248.11
$377.54
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
366.65 | 70.62B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
MCK
Mckesson Corporation
|
974.45 | 117.98B | 397.96B | 4.55B | 9.64B | 34.77 |
|
CAH
Cardinal Health Inc
|
227.13 | 53.22B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
81.47 | 9.64B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.40 | 1.10B | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Hochstufung | Jefferies | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
Insider Sell: Robert Mauch Sells Shares of Cencora Inc (COR) - GuruFocus
Dakota Wealth Management Sells 1,759 Shares of Cencora, Inc. $COR - Defense World
A Look At Cencora (COR) Valuation As Shares Trade Near Recent Highs - simplywall.st
AXQ Capital LP Takes $850,000 Position in Cencora, Inc. $COR - Defense World
NewEdge Wealth LLC Has $1.06 Million Stock Holdings in Cencora, Inc. $COR - Defense World
Bleakley Financial Group LLC Cuts Stock Position in Cencora, Inc. $COR - Defense World
Advisors Preferred LLC Sells 18,353 Shares of Cencora, Inc. $COR - Defense World
US3073EBF1 Bond Risk Analysis - TradingView
Cencora, Inc. $COR Shares Sold by CenterBook Partners LP - MarketBeat
What are Wall Street analysts' target price for Cencora stock? - MSN
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal - Finviz
NEOS Investment Management LLC Has $5.63 Million Holdings in Cencora, Inc. $COR - MarketBeat
Public Sector Pension Investment Board Grows Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora Stock Rallied 50% Last Year. Here’s the Numbers Behind Sustaining That Momentum - TIKR.com
How Cencora’s (COR) Shift to Long-Term Notes for OneOncology Has Changed Its Investment Story - simplywall.st
3 Firms Steer $3.5B Cencora, Covetrus Animal Health Merger - Law360
Cencora, Inc. (COR) Announces Merger of MWI Animal Health with C - GuruFocus
Covetrus Announces Strategic Merger with MWI Animal Health - Vet Candy
Cencora (COR) and Covetrus Announce $3.5 Billion Merger - GuruFocus
Cencora to refocus on drug distribution with $3.5 billion divestiture of animal health unit - marketscreener.com
Cencora to Receive $1.25B Cash, $2.25B Equity for MWI in $3.5B Deal; Retains 34.3% Stake - TradingView
Cencora's MWI Animal Health to Merge With Covetrus - marketscreener.com
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal - marketscreener.com
Cencora to merge MWI Animal Health with Covetrus in $3.5 billion deal - Investing.com
Animal health shake-up: Covetrus and MWI plan $3.5B merger - Stock Titan
Cencora, Inc. $COR Shares Sold by HighTower Advisors LLC - MarketBeat
Cencora, Inc. (NYSE:COR) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
OneOncology CEO on company's future after $4.9 billion deal - The Business Journals
Is the Options Market Predicting a Spike in Cencora Stock? - TradingView
Vanguard Group Inc. Boosts Stock Position in Cencora, Inc. $COR - MarketBeat
Skandinaviska Enskilda Banken AB publ Decreases Position in Cencora, Inc. $COR - MarketBeat
JPMorgan Chase & Co. Buys 821,098 Shares of Cencora, Inc. $COR - MarketBeat
PNC Financial Services Group Inc. Cuts Holdings in Cencora, Inc. $COR - MarketBeat
Cornerstone Advisory LLC Has $3.57 Million Stake in Cencora, Inc. $COR - MarketBeat
Dividend Watch: Can Cencora Inc grow without external fundingWeekly Gains Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
Cencora Closes $3.0 Billion Senior Notes Offering - marketscreener.com
Cencora, Inc. $COR Stake Raised by Tobam - MarketBeat
Cencora, Inc. $COR Shares Acquired by State of New Jersey Common Pension Fund D - MarketBeat
Shell Asset Management Co. Has $1.44 Million Stake in Cencora, Inc. $COR - MarketBeat
Assetmark Inc. Raises Stock Holdings in Cencora, Inc. $COR - MarketBeat
Aberdeen Group plc Has $48.85 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora Prices $3 Billion in Senior Notes Offering - Intellectia AI
TimesSquare Capital Management LLC Sells 22,292 Shares of Cencora, Inc. $COR - MarketBeat
Cencora Prices $3 Billion Senior Notes Offering - The Globe and Mail
Can Cencora Inc. ride the EV waveTrade Entry Summary & Consistent Return Strategy Ideas - mfd.ru
Cencora completes $3 billion senior notes offering By Investing.com - Investing.com Australia
Cencora delivers $85.9B quarter, lifts profit outlook - MSN
Cencora completes $3 billion senior notes offering - Investing.com
Cencora, Inc. Completes the Sale of $3.0 Billion Aggregate Principal Amount of the Senior Notes - marketscreener.com
Cencora Closes $3 Billion Senior Notes Offering - marketscreener.com
Cencora raises $3B to repay 364-day credit for OneOncology acquisition - Stock Titan
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):